Arca Biopharma | ABIO - الأصول





الأصول تغيير تاريخ
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Amgen USD 92.5B 1.92B 2026-03
Arca Biopharma USD 504.48M 15.86M 2026-03
Biogen USD 29.48B 43.6M 2026-03
Brainstorm Cell Therapeutics USD 755K 267K 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Capricor Therapeutics USD 326.28M 29.66M 2026-03
Cipla INR 424.96B 23.32B 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
CSL USD 37.9B 1.5B 2025-12
Cytokinetics USD 1.27B 151.06M 2026-03
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Gilead Sciences USD 56.28B 2.74B 2026-03
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Grifols EUR 23.15B 142.7M 2025-12
Laboratory Of America USD 19.09B 694.4M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
Otsuka Holdings JPY 4.21T 11.63B 2026-03
Pfizer USD 207.62B 542M 2026-03
United Therapeutics USD 6.71B 1.17B 2026-03